Phase 3 study on previously untreated chronic lymphocytic leukemia showed sustained PFS with venetoclax-obinutuzumab.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/venetoclax-obinutuzumab-clls-new-power-duo-2024a1000ket?src=rss
Author :
Publish date : 2024-11-08 08:01:55
Copyright for syndicated content belongs to the linked Source.